| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Lienert GA |
Pharmakopsychologische Untersuchungen über den Abbau der geistigen Lei... |
Verlag fur Psycholog... |
1956 |
| Roubícek J |
Similarities and differences between schizophrenia and experimental ps... |
Rev. Czechoslov. Med... |
1958 |
| Tenenbaum B |
Group Therapy with LSD-25. (A preliminary report) |
Dis.Nerv.System |
1961 |
| Spencer AM |
Hallucinogenic drugs. Specific problems |
Lancet |
1961 |
| Sandison RA |
Hallucinogenic drugs. Therapeutic applications |
Lancet |
1961 |
| Fontana AE |
El uso clínico de las drogas alusinógenas |
Acta neuropsiquiát. ... |
1961 |
| Lienert GA |
Ueber die Regression psychischer Funktionen als Folge harmakologischer... |
Med.exp. |
1961 |
| David AE, David JM |
La psilocibina, un nuevo alucinógeno, y sus posibilidades terapéuticas... |
Acta Neuropsiquiat. ... |
1961 |
| Fernandez-Cerdeño A, Leun... |
Das Erleben der oralen Regression unter Einfluss von Halluzinogenen (L... |
Z. Psycho-som. Med. |
1965 |
| Lienert G |
Mental age regression induced by lysergic acid diethylamide |
J Psychol |
1966 |
| Ward JL |
A case of change and partial regression following one LSD 25 treatment |
2nd International Co... |
1967 |
| Zegans LS, Pollard JC, Br... |
The effects of LSD-25 on creativity and tolerance to regression |
Arch Gen Psychiat |
1967 |
| Bos P |
Use of lysergic acid diethylamide in child psychiatry. |
Ceskoslovenska.Psych... |
1971 |
| Meares R, Horvath T |
A Physiological Difference Between Hallucinosis and Schizophrenia |
Brit Psychiat |
1973 |
| Soskin RA |
The Use of LSD in Time-Limited Psychotherapy |
J Nerv Ment Dis |
1973 |
| Wartmann RP |
Malerei aus Bereichen : des UnbewuBten Künstler experimentieren unter |
LSD Redaktion: Claus... |
1974 |
| Quadri SK |
Effects Of Central Acting Drugs And Ergot Derivatives On Prolactin And... |
Assertation Abst. In... |
1974 |
| Quadri SK |
Effects of Central Acting Drugs and Ergot Derivatives on Prolactin and... |
Dissertation Abstr.I... |
1974 |
| Kandel D |
Stages in Adolescent Involvement in Drug Use |
Science |
1975 |
| Stanton MD, Mintz J, Fran... |
Drug Flashbacks. II. Some Additional Findings |
Int. J. Addict. |
1976 |
| Tilson HA, Maisel AS, Jou... |
Comparison of the Effects of d-Amphetamine and Lysergic Acid Diethylam... |
Behav. Biology |
1976 |
| Richards WA |
Mystical and Archetypal Experiences of Terminal Patients in DPT-Assist... |
J of Religion and He... |
1978 |
| Domelsmith LN, Eaton TA, ... |
Photoelectron spectra of psychotropic drugs. 6. Relationships between ... |
J Med Chem |
1981 |
| Wolff K, Hay AW, Vail A, ... |
Non-prescribed drug use during methadone treatment by clinic- and comm... |
Addiction |
1996 |
| Bowdle TA, Radant AD, Cow... |
Psychedelic effects of ketamine in healthy volunteers: relationship to... |
Anesthesiology |
1998 |
| Mash DC, Allen-Ferdinand ... |
[Ibogaine:] Clinical Observations of Safety after Single Oral Dose Adm... |
College on Problems ... |
1998 |
| Pedersen W, Skrondal A |
Ecstasy and new patterns of drug use: A normal population study. |
Addiction |
1999 |
| Zhang ZF, Morgenstern H, ... |
Marijuana use and increased risk of squamous cell carcinoma of the hea... |
Cancer Epidemiol Bio... |
2000 |
| Galve-Roperh I, Sa¡nchez ... |
Anti-tumoral action of cannabinoids: involvement of sustained ceramide... |
Nat Med |
2000 |
| van Dyck CH, Malison RT, ... |
Age-related decline in central serotonin transporter availability with... |
Neurobiology of Agin... |
2000 |
| Rella JG, Nelson LS, Hoff... |
7 years of 3,4-methylenedioxymethamphetamine (MDMA) toxicity |
Int J Med Toxicol |
2000 |
| Pope HG Jr, Gruber AJ, Hu... |
Neuropsychological Performance in Long-term Cannabis Users |
Archives of General ... |
2001 |
| Degenhardt L, Hall W |
The association between psychosis and problematical drug use among Aus... |
Psychol Med |
2001 |
| MacInnes, N, Handley, SL ... |
Former chronic methylenedioxymethamphetamine (mdma or ecstasy) users r... |
J Psychopharmacology |
2001 |
| Rodgers J, Buchanan T, S... |
Differential effects of Ecstasy and cannabis on self-reports of memory... |
Hum Psychopharm Clin... |
2001 |
| Morgan MJ, McFie L, Flett... |
Ecstasy (MDMA): Are the psychological problems associated with its use... |
Psychopharmacology (... |
2002 |
| Strote J |
Increasing MDMA use among college students: results of a national surv... |
J Adolesc Health |
2002 |
| Brecht ML, von Mayrhauser... |
Differences between ecstasy-using and non-using methamphetamine users |
J Psychoactive Drugs |
2002 |
| Clare BW |
QSAR of benzene derivatives: comparison of classical descriptors, quan... |
J Comput Aided Mol D... |
2002 |
| Frank DA, Jacobs RR, Beeg... |
Level of prenatal cocaine exposure and scores on the Bayley Scales of ... |
Pediatrics |
2002 |
| Simon NG, Mattick RP |
The impact of regular ecstasy use on memory function |
Addiction |
2002 |
| Thomasius R, Petersen K, ... |
Mood, cognition and serotonin transporter availability in current and ... |
Psychopharmacology (... |
2003 |
| Verbaten MN |
Specific memory deficits in ecstasy users? The results of a meta-analy... |
Hum Psychopharmacol |
2003 |
| McCabe SE, Boyd C, Hughes... |
Sexual identity and substance use among undergraduate students |
Subst Abus |
2003 |
| Boyd CJ, McCabe SE, d'Arc... |
Ecstasy use among college undergraduates: gender, race and sexual iden... |
J Subst Abuse Treat |
2003 |
| Reijneveld SA, Crone MR, ... |
The effect of a severe disaster on the mental health of adolescents: a... |
Lancet |
2003 |
| Cozzi NV, Foley KF |
Methcathinone is a substrate for the serotonin uptake transporter |
Pharmacol Toxicol |
2003 |
| Halpern JH, Pope HG Jr, S... |
Residual neuropsychological effects of illicit 3,4-methylenedioxymetha... |
Drug Alcohol Depend |
2004 |
| Fergusson DM, Horwood LJ,... |
Tests of causal linkages between cannabis use and psychotic symptoms |
Addiction |
2005 |
| Westover AN, McBride S, H... |
Stroke in young adults who abuse amphetamines or cocaine: a population... |
Arch Gen Psychiatry |
2007 |
| Jager G, de Win MM, van d... |
Assessment of Cognitive Brain Function in Ecstasy Users and Contributi... |
Neuropsychopharmacol... |
2007 |
| Kim SY, Anderson IB, Dyer... |
High-risk behaviors and hospitalizations among gamma hydroxybutyrate (... |
Am J Drug Alcohol Ab... |
2007 |
| Kirsch I, Deacon BJ, Hued... |
Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data ... |
Public Library of Sc... |
2008 |
| Aldington S, Harwood M, C... |
Cannabis use and risk of lung cancer: a case-control study |
Eur Respir J |
2008 |
| Griffiths RR, Richards WA... |
Mystical-type experiences occasioned by psilocybin mediate the attribu... |
J Psychopharm |
2008 |
| Rogers G, Elston J, Garsi... |
The harmful health effects of recreational ecstasy: a systematic revie... |
Health Technol Asses... |
2009 |
| Brunt TM, Rigter S, Hoek ... |
An analysis of cocaine powder in the Netherlands: content and health h... |
Addiction |
2009 |
| Kuntsche E, Cooper ML |
Drinking to have fun and to get drunk: Motives as predictors of weeken... |
Drug Alcohol Depend |
2010 |
| Wu LT, Woody GE, Yang C, ... |
Recent national trends in Salvia divinorum use and substance-use disor... |
Subst Abuse Rehab |
2011 |
| Wilson MD, Ferguson RW, M... |
Monitoring trends in dextromethorphan abuse using the National Poison ... |
Clinical Toxicology |
2011 |
| Halpern JH, Sherwood AR, ... |
Reply to Parrott (2011), Fisk et al (2011) and Rodgers et al (2011) |
Addiction |
2011 |
| Brunt TM, Koeter MW, Nies... |
Linking the pharmacological content of ecstasy tablets to the subjecti... |
Psychopharmacology (... |
2011 |
| Dregan A, Gulliford MC |
Is Illicit Drug Use Harmful to Cognitive Functioning in the Midadult Y... |
Am J Epidemiol |
2011 |
| Caldeira KM, O'Grady KE, ... |
Marijuana use trajectories during the post-college transition: Health ... |
Drug Alcohol Depend |
2012 |
| Degenhardt L, Coffey C, R... |
The persistence of the association between adolescent cannabis use and... |
Addiction |
2012 |
| O'Connor AD, Padilla-Jone... |
Prevalence of Rhabdomyolysis in Sympathomimetic Toxicity: a Comparison... |
J Med Toxicol |
2015 |
| Battal D, Barnes AJ, Cast... |
Urine Mescaline Screening With a Biochip Array Immunoassay and Quantif... |
Ther Drug Monit |
2015 |
| Zhou Y, Luo W, Cao XB, Zh... |
[Overdose of heroin and influencing factors in intravenous drug users ... |
Zhonghua Liu Xing Bi... |
2016 |
| Brandt SD, Kavanagh PV, W... |
Return of the lysergamides. Part II: Analytical and behavioural charac... |
Drug Test Anal |
2016 |
| Carbonaro TM, Bradstreet ... |
Survey study of challenging experiences after ingesting psilocybin mus... |
J Psychopharmacol |
2016 |
| Klein LM, Cozzi NV, Daley... |
Receptor binding profiles and behavioral pharmacology of ring-substitu... |
Neuropharmacology |
2018 |
| Tapper EB, Parikh ND |
Mortality due to cirrhosis and liver cancer in the United States, 1999... |
BMJ |
2018 |
